Evaluation of the antibacterial efficacy of diesters of azelaic acid

European Journal of Pharmaceutical Sciences

Volumn 21, Issue 5, 2004, Pages 589-596

  Charnock, Colin ^a   Brudeli, Bjarne ^b   Klaveness, Jo ^b,c  

^a OSLO METROPOLITAN UNIVERSITY   (Norway)

^b Drug Discovery Laboratory AS   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Antibacterial efficacy; Azelaic acid; Diester

Indexed keywords

AGAR; ANTIINFECTIVE AGENT; AZELAIC ACID; BIS[(BUTANOYLOXY)METHYL]NONANEDIOATE; BIS[(HEXANOYLOXY)METHYL]NONANEDIOATE; ESTER DERIVATIVE; UNCLASSIFIED DRUG;

AGAR GEL DIFFUSION; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL SURVIVAL; COMMERCIAL PHENOMENA; CULTURE MEDIUM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EVALUATION; GROWTH INHIBITION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; PRIORITY JOURNAL; SKIN DISEASE; SKIN FLORA; STATISTICAL SIGNIFICANCE;

ANTI-BACTERIAL AGENTS; DICARBOXYLIC ACIDS; DRUG EVALUATION, PRECLINICAL; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 1842503025     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2003.12.006     Document Type: Article

References (29)

1. Arpigny J.L., Jaeger K.-E. Bacterial lipolytic enzymes: classification and properties. Biochem. J. 343:1999;177-183.
2. Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A., Nagai Y., Iwama N., Asano K., Naimi T., Kuroda H., Cui L., Yamamoto K., Hiramatsu K. Genome and virulence determinant of high virulence community-acquired MRSA. Lancet. 359:2002;1819-1827.
3. Bojar R.A., Holland K.T., Leeming K.T., Cunliffe W.J. Azelaic acid: its uptake and mode of action in Staphylococcus epidermidis NCTC 11047. J. Appl. Bacteriol. 64:1988;497-504.
4. Bojar R.A., Holland K.T., Cunliffe W.J. The in vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37. J. Antimicrob. Chemother. 28:1991;843-853.
5. Bojar R.A., Cunliffe W.J., Holland K.T. Disruption of the transmembrane pH gradient-a possible mechanism for the antibacterial action of azelaic acid in Propionibacterium acnes and Staphylococcus epidermidis. J. Antimicrob. Chemother. 34:1994;321-330.
6. Eady E.A., Gloor M., Leyden J.J. Propionibacterium acnes resistance: a worldwide problem. Dermatology. 206:2003;54-56.
7. Farrell A.M., Foster T.J., Holland K.T. Molecular analysis and expression of the lipase of Staphylococcus epidermidis. J. Gen. Microbiol. 139:1993;267-277.
8. Fitton A., Goa K.L. Azelaic acid-a review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs. 41:1992;780-798.
9. Gollnick H.P.M., Krautheim A. Topical treatment in acne: current status and future aspects. Dermatology. 206:2003;29-36.
10. Gribbon E.M., Cunliffe W.J., Holland K.T. Interaction of Propionibacterium acnes with skin lipids in vitro. J. Gen. Microbiol. 139:1993;1745-1751.
11. Hjorth N., Graupe K. Azelaic acid for the treatment of acne. Acta Derm. Venereol. Suppl. (Stockholm). 143:1989;45-48.
12. Holland, K.T., 1989. Microbiology of acne. In: Marks, R. (Ed.), Acne. Martin Dunitz, London, pp. 178-210.
13. Hu F., Mah K., Teramura D.J. Effects of dicarboxylic acids on normal and malignant melanocytes in culture. Br. J. Dermatol. 114:1986;17-26.
14. Ingham E., Holland K.T., Gowland G., Cunliffe W.J. Partial purification and characterization of lipase (EC 3.1.1.3) from Propionibacterium acnes. J. Gen. Microbiol. 124:1981;393-401.
15. Jain A., Sangal L., Basal E., Kaushal G.P., Agarwal S.K. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils. Dermatol. Online J. 8:2002;2.
16. Jansen A.B., Russell T.J. Some novel penicillin derivatives. J. Chem. Soc. 65:1965;2127-2132.
17. Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I., Cui L., Oguchi A., Aoki K., Nagai Y., Lian J., Ito T., Kanamori M., Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y., Takahashi N.K., Sawano T., Inoue R., Kaito C., Sekimizu K., Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M., Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M., Ogasawara N., Hayashi H., Hiramatsu K. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet. 357:2001;1225-1240.
18. Lee C.Y., Iandolo J.J. Lysogenic conversion of staphylococcal lipase is caused by insertion of the bacteriophage L54a genome into the lipase structural gene. J. Bacteriol. 166:1986;385-391.
19. Leeming J.P., Holland K.T., Bojar R.A. The in vitro antimicrobial effect of azelaic acid. Br. J. Dermatol. 115:1986;551-556.
20. Longshaw C.M., Farrell A.M., Wright J.D., Holland K.T. Identification of a second lipase gene, gehD, in Staphylococcus epidermidis: comparison of sequence with those of other staphylococcal lipases. Microbiology. 146:2000;1419-1427.
21. Mingrone G., Greco A.V., Nazzaro-Porro M., Passi S. Toxicity of azelaic acid. Drugs Exp. Clin. Res. 9:1983;447-455.
22. Miskin J.E., Farrell A.M., Cunliffe W.J., Holland K.T. Propionibacterium acnes, a resident of lipid-rich human skin, produces a 33 kDa extracellular lipase encoded by gehA. Microbiology. 143:1997;1745-1755.
23. Nicolaides N. Skin lipids: their biochemical uniqueness. Science. 186:1974;19-26.
24. Nicolaides N., Wells G.C. On the biogenesis of the free fatty acids in human skin surface fat. J. Invest. Dermatol. 29:1957;423-433.
25. Noble W.C. Observations on the surface flora of the skin and on the skin pH. Br. J. Dermatol. 80:1968;279-281.
26. Passi S., Nazzaro-Porro M., Picardo M., Breathnach A., Confaloni A., Serlupi-Crescenzi A. Antimitochondrial effect of saturated medium chain-length (C8 to C13) dicarboxylic acids. Biochem. Pharmacol. 33:1984;103-108.
27. Simons J.W., van Kampen M.D., Riel S., Gotz F., Egmond M.R., Verheij H.M. Cloning, purification and characterization of the lipase from Staphylococcus epidermidis-comparison of the substrate selectivity with those of other microbial lipases. Eur. J. Biochem. 253:1998;675-683.
28. Sintov A.C., Behar-Canetti C., Friedman Y., Tamarkin D. Percutaneous penetration and skin metabolism of ethylsalicyclate-containing agent, TU-2100: in-vitro and in-vivo evaluation in guinea pigs. J. Control Release. 79:2002;113-122.
29. Ulich L.H., Adams R. The reaction between acid halides and aldehydes. J. Am. Chem. Soc. 43:1921;660-667.